Colorectal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Part I – Surgery
- People who have been diagnosed with colon or rectal cancer at an early to intermediate stage (stage I, II, or III)
- People who are able to understand and sign a written consent form agreeing to take part
- People who are scheduled for surgery with the goal of removing the cancer completely (including some cases where a full removal may not be possible but is still attempted)
Part II – Surveillance (follow-up phase)
- People who have already taken part in Part I of this trial
- People whose cancer has been confirmed as stage III colorectal cancer
- People who have had their cancer surgically removed and for whom the treating doctor considers additional chemotherapy after surgery to be appropriate
Who may not be able to join:
Part I – Surgery
- People whose colorectal cancer is linked to an inherited condition such as familial colonic polyposis or Lynch syndrome
- People who have inflammatory bowel disease, such as Crohn's disease or ulcerative colitis
- People whose cancer has been confirmed to have spread to other parts of the body (distant metastases)
- People whose cancer was found in a polyp that was removed during a separate bowel procedure
- People who the trial team believes are unlikely to follow the study requirements or attend all required visits
Part II – Surveillance
- People who do not receive chemotherapy after surgery
- People who received chemotherapy and radiation therapy before their surgery
- People found to have a second, unrelated cancer (other than certain non-melanoma skin cancers) at the time of surgery
- People who have had another cancer (other than colorectal cancer or certain non-melanoma skin cancers) within the three years before being assessed for eligibility
- People who the trial team believes are unlikely to follow the study requirements or attend all required visits
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Claus L Andersen, PhD, Aarhus University Hospital
Phone: +45 7845 5319
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The prognostic value of ctDNA status
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.